Coming soon — autonomous food delivery on Uber Eats. Photo courtesy of Nuro and Uber

Houstonians will soon be able to get completely autonomous delivery of their dinners, groceries, and more thanks to a new 10-year partnership.

Uber Technologies, Inc. and Nuro have cut a deal that will provide autonomous, electric vehicles for food deliveries in Houston and Mountain View, California, beginning his fall, according to a news release. A Bay Area expansion will follow, but Houston's no stranger to Nuro-powered deliveries. California-based Nuro has launched five delivery pilot programs in Houston since 2019 with partners Kroger, Walmart, CVS, Domino's, and FedEx.

With this new partnership, users will have access to meals, groceries, and other goods available on the Uber Eats platform — as well as the opportunity to support local businesses.

“Nuro and Uber share a vision in which technology can make everyday life just a little bit easier,” says Noah Zych, global head of autonomous mobility and delivery at Uber, in the release. “Nuro’s distinctive autonomous vehicles are a great match for the Uber platform, and this partnership will bring a compelling combination of innovation alongside the convenience, affordability and reliability our customers and merchants have come to expect.”

Nuro, which recently closed a $600 million series D round just under a year ago, is reportedly the first company to operate fully autonomous vehicles in three states —Arizona, California, and Texas.

“Our partnership with Uber underscores Nuro’s track record of partnering with the world’s leading brands to make autonomous delivery a seamless experience,” says Cosimo Leipold, head of partnerships at Nuro, in the release. “With our unique autonomous delivery vehicles and Uber’s phenomenal scale and reach, we can expand food delivery options from your favorite local mom-and-pop restaurants all the way to nationwide chains.”

The company tapped Houston as its first full-scale operational city. Nuro previously told InnovationMap that was because the city offered a wide range of variation in the infrastructure across Houston's neighborhoods.

"Houston is our first full-scale operations city," Sola Lawal, product operations manager in Houston, told InnovationMap in January 2020. "All eyes at Nuro are focused on Houston."

Autonomous Uber Eats coming soon — thanks to Nuro. Photo courtesy of Nuro and Uber

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”

Chevron enters the lithium market with major Texas land acquisition

to market

Chevron U.S.A., a subsidiary of Houston-based energy company Chevron, has taken its first big step toward establishing a commercial-scale lithium business.

Chevron acquired leaseholds totaling about 125,000 acres in Northeast Texas and southwest Arkansas from TerraVolta Resources and East Texas Natural Resources. The acreage contains a high amount of lithium, which Chevron plans to extract from brines produced from the subsurface.

Lithium-ion batteries are used in an array of technologies, such as smartwatches, e-bikes, pacemakers, and batteries for electric vehicles, according to Chevron. The International Energy Agency estimates lithium demand could grow more than 400 percent by 2040.

“This acquisition represents a strategic investment to support energy manufacturing and expand U.S.-based critical mineral supplies,” Jeff Gustavson, president of Chevron New Energies, said in a news release. “Establishing domestic and resilient lithium supply chains is essential not only to maintaining U.S. energy leadership but also to meeting the growing demand from customers.”

Rania Yacoub, corporate business development manager at Chevron New Energies, said that amid heightening demand, lithium is “one of the world’s most sought-after natural resources.”

“Chevron is looking to help meet that demand and drive U.S. energy competitiveness by sourcing lithium domestically,” Yacoub said.

---

This article originally appeared on EnergyCapital.